Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...

Rural ILD patients experience significant diagnostic and treatment delays compared to urban counterparts, highlighting access challenges. Telehealth shows promise in improving access to ILD care, ...

Patients with rheumatoid arthritis (RA) treated with tofacitinib (Xeljanz) were 69% less likely to develop interstitial lung disease (ILD), compared with those treated with adalimumab (Humira), ...

Neil B. Minkoff, MD: Dr Hummers, please share the prevalence of chronic fibrosis ILD [interstitial lung disease] with the progressive phenotype? Laura Hummers, MD: It’s tricky to determine a phenotype ...

Please provide your email address to receive an email when new articles are posted on . A CHEST project hopes to educate health care workers on best practices in interstitial lung disease diagnosis.

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.

AllRock Bio, Inc., a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and ...